ATE450549T1 - Monoklonale antikörper mit spezifität für fetale erythroidzellen - Google Patents
Monoklonale antikörper mit spezifität für fetale erythroidzellenInfo
- Publication number
- ATE450549T1 ATE450549T1 AT05736009T AT05736009T ATE450549T1 AT E450549 T1 ATE450549 T1 AT E450549T1 AT 05736009 T AT05736009 T AT 05736009T AT 05736009 T AT05736009 T AT 05736009T AT E450549 T1 ATE450549 T1 AT E450549T1
- Authority
- AT
- Austria
- Prior art keywords
- specificity
- cells
- monoclonal antibodies
- erythroid cells
- fetal
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70582—CD71
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04007811 | 2004-03-31 | ||
PCT/EP2005/003371 WO2005100401A2 (en) | 2004-03-31 | 2005-03-31 | Monoclonal antibodies with specificity for fetal erythroid cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE450549T1 true ATE450549T1 (de) | 2009-12-15 |
Family
ID=35150543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05736009T ATE450549T1 (de) | 2004-03-31 | 2005-03-31 | Monoklonale antikörper mit spezifität für fetale erythroidzellen |
Country Status (9)
Country | Link |
---|---|
US (6) | US7858757B2 (de) |
EP (1) | EP1732951B1 (de) |
JP (1) | JP4756032B2 (de) |
AT (1) | ATE450549T1 (de) |
AU (1) | AU2005233254B2 (de) |
CA (1) | CA2561830C (de) |
DE (1) | DE602005018028D1 (de) |
ES (1) | ES2337702T3 (de) |
WO (1) | WO2005100401A2 (de) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4756032B2 (ja) * | 2004-03-31 | 2011-08-24 | アトナーゲン アクチエンゲゼルシャフト | 胎児赤血球細胞に対して特異性を有するモノクローナル抗体 |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
DE102006062619B4 (de) * | 2006-12-29 | 2012-04-26 | Medion Diagnostics Ag | Verfahren zur Bestimmung von minoren Zellpopulationen in heterogenen Zellpopulationen |
CA2731991C (en) | 2008-08-04 | 2021-06-08 | Gene Security Network, Inc. | Methods for allele calling and ploidy calling |
EP2473638B1 (de) | 2009-09-30 | 2017-08-09 | Natera, Inc. | Verfahren zur nichtinvasiven pränatalen ploidiezuordnung |
WO2011146632A1 (en) | 2010-05-18 | 2011-11-24 | Gene Security Network Inc. | Methods for non-invasive prenatal ploidy calling |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
SI2646470T1 (sl) | 2010-11-30 | 2017-05-31 | F. Hoffmann-La Roche Ag | Protitelesa proti receptorjem antitransferina in njihova uporaba za prenos terapevtskega enoverižnega variabilnega fragmenta (scfv) prek krvno-možganske pregrade |
JP6328934B2 (ja) | 2010-12-22 | 2018-05-23 | ナテラ, インコーポレイテッド | 非侵襲性出生前親子鑑定法 |
AU2011358564B9 (en) | 2011-02-09 | 2017-07-13 | Natera, Inc | Methods for non-invasive prenatal ploidy calling |
US10466160B2 (en) | 2011-08-01 | 2019-11-05 | Celsee Diagnostics, Inc. | System and method for retrieving and analyzing particles |
US9174216B2 (en) | 2013-03-13 | 2015-11-03 | DeNovo Science, Inc. | System for capturing and analyzing cells |
US9404864B2 (en) | 2013-03-13 | 2016-08-02 | Denovo Sciences, Inc. | System for imaging captured cells |
US9103754B2 (en) | 2011-08-01 | 2015-08-11 | Denovo Sciences, Inc. | Cell capture system and method of use |
US20130122492A1 (en) | 2011-11-14 | 2013-05-16 | Kellbenx Inc. | Detection, isolation and analysis of rare cells in biological fluids |
EP4008270A1 (de) | 2012-06-22 | 2022-06-08 | Preprogen LLC | Verfahren zur gewinnung fötaler zellen und fötaler zellkomponenten |
US9752181B2 (en) | 2013-01-26 | 2017-09-05 | Denovo Sciences, Inc. | System and method for capturing and analyzing cells |
US9707562B2 (en) | 2013-03-13 | 2017-07-18 | Denovo Sciences, Inc. | System for capturing and analyzing cells |
US9856535B2 (en) | 2013-05-31 | 2018-01-02 | Denovo Sciences, Inc. | System for isolating cells |
US10391490B2 (en) | 2013-05-31 | 2019-08-27 | Celsee Diagnostics, Inc. | System and method for isolating and analyzing cells |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
WO2015048535A1 (en) | 2013-09-27 | 2015-04-02 | Natera, Inc. | Prenatal diagnostic resting standards |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
CN113774132A (zh) | 2014-04-21 | 2021-12-10 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
US20160130553A1 (en) * | 2014-05-15 | 2016-05-12 | Kellbenx Incorporated | PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING |
JP2017521091A (ja) * | 2014-05-15 | 2017-08-03 | ケルベンクス インコーポレイテッド | 診断試験用の胎児有核赤血球(nrbc)の調製 |
EP3179248A4 (de) * | 2014-08-05 | 2017-06-14 | Fujifilm Corporation | Verfahren zur trennung von nukleierten roten blutkörperchen |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
JP6234542B1 (ja) | 2016-12-27 | 2017-11-22 | 株式会社 TL Genomics | 胎児細胞由来染色体dnaの取得方法 |
CA3049139A1 (en) | 2017-02-21 | 2018-08-30 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
JP6980904B2 (ja) | 2017-08-29 | 2021-12-15 | バイオ−ラッド ラボラトリーズ インコーポレイテッド | 細胞を単離し分析するためのシステムおよび方法 |
WO2019078277A1 (ja) | 2017-10-19 | 2019-04-25 | 株式会社 TL Genomics | 細胞分級用チップ |
US10946380B2 (en) * | 2018-01-19 | 2021-03-16 | International Business Machines Corporation | Microfluidic chips for particle purification and fractionation |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
US10633693B1 (en) | 2019-04-16 | 2020-04-28 | Celsee Diagnostics, Inc. | System and method for leakage control in a particle capture system |
US20230258663A9 (en) | 2019-05-02 | 2023-08-17 | Kellbenx Incorporated | Filtration-based methods for preparing fetal nucleated red blood cells (nrbcs) for diagnostic testing |
US11273439B2 (en) | 2019-05-07 | 2022-03-15 | Bio-Rad Laboratories, Inc. | System and method for target material retrieval from microwells |
US11578322B2 (en) | 2019-05-07 | 2023-02-14 | Bio-Rad Laboratories, Inc. | System and method for automated single cell processing |
KR20220033484A (ko) | 2019-06-14 | 2022-03-16 | 바이오 래드 래버러토리스 인코오포레이티드 | 자동화된 단일 세포 처리 및 분석을 위한 시스템 및 방법 |
US11504719B2 (en) | 2020-03-12 | 2022-11-22 | Bio-Rad Laboratories, Inc. | System and method for receiving and delivering a fluid for sample processing |
US11827702B2 (en) | 2021-09-01 | 2023-11-28 | Biogen Ma Inc. | Anti-transferrin receptor antibodies and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10035433C2 (de) * | 2000-07-20 | 2002-07-18 | Tuma Wolfgang | Schonende Hochanreicherung von fetalen Zellen aus pripherem Blut und Verwendung derselben |
ITRM20010322A1 (it) | 2001-06-08 | 2002-12-09 | Consiglio Nazionale Ricerche | Metodo non ivasivo su sangue materno per lo screening e la diagnosi di aneuploidie fetali. |
JP4756032B2 (ja) * | 2004-03-31 | 2011-08-24 | アトナーゲン アクチエンゲゼルシャフト | 胎児赤血球細胞に対して特異性を有するモノクローナル抗体 |
-
2005
- 2005-03-31 JP JP2007505500A patent/JP4756032B2/ja active Active
- 2005-03-31 AT AT05736009T patent/ATE450549T1/de active
- 2005-03-31 EP EP05736009A patent/EP1732951B1/de active Active
- 2005-03-31 AU AU2005233254A patent/AU2005233254B2/en active Active
- 2005-03-31 ES ES05736009T patent/ES2337702T3/es active Active
- 2005-03-31 CA CA2561830A patent/CA2561830C/en active Active
- 2005-03-31 DE DE602005018028T patent/DE602005018028D1/de active Active
- 2005-03-31 WO PCT/EP2005/003371 patent/WO2005100401A2/en active Application Filing
- 2005-03-31 US US10/599,512 patent/US7858757B2/en active Active
-
2010
- 2010-12-28 US US12/979,535 patent/US8536312B2/en active Active
-
2013
- 2013-09-16 US US14/028,027 patent/US9194871B2/en active Active
-
2015
- 2015-08-13 US US14/825,516 patent/US20160039932A1/en not_active Abandoned
- 2015-10-14 US US14/882,995 patent/US9453841B2/en active Active
-
2022
- 2022-11-18 US US17/989,895 patent/US20230324383A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2561830C (en) | 2013-05-21 |
US20070275418A1 (en) | 2007-11-29 |
US20160039932A1 (en) | 2016-02-11 |
EP1732951A2 (de) | 2006-12-20 |
AU2005233254A1 (en) | 2005-10-27 |
JP4756032B2 (ja) | 2011-08-24 |
US20140154704A1 (en) | 2014-06-05 |
US20110129916A1 (en) | 2011-06-02 |
AU2005233254B2 (en) | 2011-11-24 |
US9194871B2 (en) | 2015-11-24 |
WO2005100401A2 (en) | 2005-10-27 |
US7858757B2 (en) | 2010-12-28 |
WO2005100401A3 (en) | 2006-06-15 |
US9453841B2 (en) | 2016-09-27 |
US8536312B2 (en) | 2013-09-17 |
DE602005018028D1 (de) | 2010-01-14 |
US20230324383A1 (en) | 2023-10-12 |
ES2337702T3 (es) | 2010-04-28 |
EP1732951B1 (de) | 2009-12-02 |
US20160084837A1 (en) | 2016-03-24 |
CA2561830A1 (en) | 2005-10-27 |
JP2007530629A (ja) | 2007-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE450549T1 (de) | Monoklonale antikörper mit spezifität für fetale erythroidzellen | |
NZ623706A (en) | Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof | |
DK1881064T3 (da) | HCV-anti-kerne monoklonalt antistof | |
ATE468355T1 (de) | Diabody-typ bispezifischer antikörper | |
MY171554A (en) | Monoclonal antibody and immunoassay using the same | |
EA200971114A1 (ru) | Определение антигенов, расположенных на эритроцитах, и антиэритроцитарных антител | |
ATE464374T1 (de) | Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen | |
WO2008122793A3 (en) | Blood group antibody screening | |
ATE277083T1 (de) | Antikörper, die spezifisch für fullerene sind | |
WO2008025964A3 (en) | Antibodies to an epitope of agr2. assays and hybridomas | |
MX347002B (es) | Ensayo de psa y reactivo para el mismo. | |
WO2004106385A3 (en) | Monoclonal antibodies specific for buprenorphine and metabolites thereof | |
WO2006075142A3 (en) | FORMS OF FACTOR XIIa | |
EP1072888A3 (de) | Immunoassay-Verfahren und -Reagens für HIV-1p24-Antigen | |
WO2005114203A3 (en) | Dominant b cell epitopes and methods of making and using thereof | |
PL1879029T3 (pl) | Zestaw do immunologicznego wykrywania związanej z enzymem neuroglobiny i jego zastosowanie | |
WO2006020263A3 (en) | Cytoxan antibodies and immunoassay | |
AU2003283240A8 (en) | Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells | |
WO2006085092A3 (en) | Methods and uses of antibodies in the purification of interferon | |
WO2006044888A3 (en) | Reagents for urine-based immunological assays | |
WO2007011698A3 (en) | Humanized antibody conjugates and related methods, assays, reagents, and kits | |
WO2006060188A3 (en) | Anti-tenascin monoclonal antibody immunoassays and diagnostic kits | |
EP1359161A3 (de) | Monoklonaler Antikörper, der spezifische gegen tartratbeständige Säurephosphatase 5b gerichtet ist und dessen Verwendung | |
WO2006005940A3 (en) | Monoclonal anti-glut2 antibody | |
MX2022014580A (es) | Ensayo de multiplex doble para multiples isotipos de inmunoglobulina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1732951 Country of ref document: EP |